Stock Events

Stereotaxis 

€1.77
-€0.02-1.12% Friday 07:02

Statistics

Day High
1.77
Day Low
1.77
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
15.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
-0.07
-0.06
-0.06
-0.05
Expected EPS
-0.0525
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RJR1.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks worldwide. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters; and Pegasus coronary guidewire for cardiology procedures. Further, the company?s disposables and other accessories include V-CAS catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. Stereotaxis, Inc. has strategic alliances with Siemens AG Medical Solutions; Philips Medical Systems; and Biosense Webster, Inc. The company markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
Show more...
CEO
Country
US
ISIN
US85916J4094
WKN
000A1J09L

Listings